Big, big market opportunity opening up with Permatrex as a delivery platform they can license out to other pharmas as well as for use in their own proprietary drugs, if the system is tolerated and effective this could be another big parallel market they could open up.
Ann: Botanix Accelerates Clinical Program with First Human Study, page-4
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
0.010(6.25%) |
Mkt cap ! $333.3M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 18.0¢ | 16.0¢ | $3.403M | 19.98M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 11400 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 1048293 | 11 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| BOT (ASX) Chart |